Tan Lee Su-Leng (CIK 2141883) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy BGLC (338,709 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | BioNexus Gene Lab Corp (BGLC) | Chief Executive Officer | Buy | 338,709 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14